News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
The National Institute for Allergy and Infectious Diseases (NIAID) was awarded an Excellence in Technology Transfer award from the 2021 Federal Laboratory Consortium (FLC) awards. The FLC gave out 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response
Are you interested in licensing a COVID-19 vaccine? As the pandemic continues, a safe, affordable, and efficacious vaccine continues to be of urgent importance. Scientists at NIAID have developed a vaccine against COVID-19 by utilizing the well-characterized vesicular stomatitis virus (VSV) encoding
Abraham Lincoln was the only president to have applied for a patent. His invention was never commercialized. As a young man, Lincoln took a flat boat load of merchandise down the Mississippi River from his then home in New Salem, Illinois, to New Orleans, Louisiana. At one point the boat slid onto a